Where to Inject Zepbound or Wegovy: The Three Sites, Bruising, and After a C-Section

The short answer

Zepbound and Wegovy go under the skin of the stomach area, the thigh or the upper arm, and both labels say blood levels come out about the same from all three^1,2. So the best place is the one you can reach comfortably. Move the spot a little every week, and keep the needle out of scars, including a C-section scar.

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure here is cited inline to its primary source, the trial or the FDA label, so you can check it. This is background reading, not medical advice.

The sites, presentation by presentation

The broad rule is the same everywhere. The fine print differs by device, and it is worth reading the instructions for the exact pen or vial in your fridge, because the prescribing information tells clinicians to retrain you whenever the presentation changes¹.

Sources: Zepbound Instructions for Use¹; Wegovy Instructions for Use²; Mounjaro Instructions for Use⁴.

Does the site change how well it works?

No, according to the labels. Zepbound's clinical pharmacology section says similar exposure was achieved whether tirzepatide was injected in the abdomen, thigh or upper arm, and Wegovy's says the same for semaglutide^1,2. Wegovy's dosing section adds that the injection site can be changed without any change in dose². Ozempic's label reports the same for semaglutide in its pens³.

That settles the most common worry. Stomach shots do not work "faster" or "better" than thigh shots in any data the labels report, so choose by comfort, by where you have the most soft tissue, and by where a toddler is least likely to be climbing on you that evening.

After a C-section: what the instructions cover, and what they do not

No label or instruction leaflet mentions a cesarean incision by name. What they do say applies directly. The Zepbound and Mounjaro vial instructions say not to inject into scars or damaged skin, or into skin that is tender, bruised or hard^1,4. The Wegovy pen instructions say to avoid scars and stretch marks². A healing C-section scar, and any tender skin around it, falls squarely inside those words.

What the labels do not tell you is how far from the incision is far enough, or when a healed scar area becomes ordinary skin again. Nobody has published data on that, and we are not going to invent a number. Ask your surgeon or OB before injecting anywhere on the lower abdomen in the months after a cesarean. The simplest workaround needs no permission: the thigh, and the back of the upper arm if someone can help, deliver the same exposure^1,2.

Two other postpartum situations come up often:

• Loose skin. The Wegovy pen instructions suggest that if you have trouble injecting, you switch to a firmer site such as the thigh or upper arm, or stand up when you inject into the lower stomach². Soft postpartum skin is exactly when that tip helps. Our page on loose skin after GLP-1 weight loss covers what happens to it over time.
• Diastasis recti. Abdominal muscle separation is not mentioned in any of these labels. These injections go under the skin, not into muscle, but if the area is sore or you are in pelvic floor or core rehab, ask the clinician treating it. The stretch marks guide covers the skin side.

Timing matters as much as placement. Zepbound's label says to stop once a pregnancy is recognized, and Wegovy's says to stop at least 2 months before a planned pregnancy^1,2. If you are nursing, both injectable labels ask you and your clinician to weigh the developmental and health benefits of breastfeeding against your clinical need for the drug, since there are no data on effects in the breastfed infant^1,2. See timing a GLP-1 after birth and GLP-1s and breastfeeding.

Bruising, lumps and itching: how often

Zepbound's label reports more skin reactions at the injection spot than the semaglutide labels do, though the trials differ and cannot be ranked head to head. In Zepbound's weight-loss trials, 6% to 8% reported them, counting bruising, redness, itching, pain and rash, against 2% on placebo. They were concentrated in people who developed antibodies to the drug: 11.3% of those, against 1% of everyone else¹. Wegovy's trials reported 1.4% against 1% on placebo²; Mounjaro's diabetes trials 3.2% against 0.4%⁴; Ozempic's 0.2%³.

What the instructions say to do:

• Rotate within the area. The Zepbound vial instructions say rotation reduces the risk of lipodystrophy, which shows up as pits or thickened skin, and of small lumps from protein deposits under the skin¹.
• Skip damaged spots. Do not inject where the skin is pitted, thickened, lumpy, bruised or tender¹.
• Bleeding. Press gauze or a cotton ball on the spot and do not rub it¹.
• Not on top of other shots. Do not use the same spot you use for another injected medicine¹.

Widespread rash, hives or swelling beyond the injection spot is a different matter; see itching and skin reactions on a GLP-1.

Pens and vials: what changes in your hands

A single-dose Zepbound pen is held against the skin for up to 10 seconds, and the vial instructions say to keep the needle in for at least 5 seconds after pushing the plunger¹. Vials need a fresh syringe and needle every time, such as a 1 mL syringe that can measure a 0.5 or 0.6 mL dose¹. Whether to pinch the skin is something your clinician should tell you for the Zepbound vial; the Wegovy prefilled syringe instructions say to pinch and insert at a 45 degree angle^1,2. If you are still choosing where to get a prescription, see the GLP-1 providers for women board.

Where this sits on the evidence scale

The site guidance is regulatory-grade: the three areas, the equal exposure and the rotation rule come straight from FDA-approved labels and instructions, backed by pharmacology studies. The reaction rates come from placebo-controlled trials. The C-section question has no direct research behind it at all, only the general rule against injecting into scars, which is why your surgeon or OB gets the final word on the lower abdomen.